Table 3 Perceived HPV vaccine usefulness against cervical cancer
N | Strongly Agree | Somewhat Agree | Somewhat Disagree | Strongly Disagree | |
|---|---|---|---|---|---|
Age group (years) | |||||
18–29 | 103 | 39 (29–48) | 44 (34–53) | 15 (8–21) | 3 (0–8) |
30–44 | 117 | 43 (34–52) | 43 (34–52) | 11 (5–17) | 3 (0–7) |
45–59 | 152 | 55 (47–63) | 35 (27–42) | 9 (5–14) | 1 (0–3) |
60–69 | 88 | 59 (49–69) | 31 (21–40) | 10 (4–17) | 0 (0–4) |
Schooling | |||||
< College | 162 | 62 (55–70) | 28 (21–35) | 8 (4–12) | 1 (0–3) |
College | 148 | 41 (33–49) | 40 (32–48) | 15 (9–21) | 4 (1–7) |
University | 150 | 42 (34–50) | 47 (39–55) | 11 (6–16) | 1 (0–2) |